The present invention provides a use of SQB-
DNA nanostructures, prepared using
DNA origami technology, for inducing differentiation into
nerve cells or nerve
cell regeneration, or treating nerve damage or neurological diseases. The present invention is the first instance of achieving nerve
recovery through precise ligand presentation using
DNA origami nanostructures, and the widespread use of SQB as a therapeutic
drug for various types of nerve damage and neurological diseases requiring nerve regeneration is expected due to the provision of the present invention.